Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04944992
What this trial is testing

Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Merck Sharp & Dohme LLC 145
Not applicableStudy completedNCT06321211
What this trial is testing

Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD

Who this might be right for
Fatty Liver, Nonalcoholic
Singapore Institute of Technology 30
Testing effectiveness (Phase 2)UnknownNCT06302049
What this trial is testing

Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis

Who this might be right for
Fatty Liver DiseaseSteatohepatitis, Nonalcoholic
Sadat City University 46
Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Not applicableEnded earlyNCT01260246
What this trial is testing

Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNonalcoholic Steatohepatitis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 12
Post-approval studies (Phase 4)UnknownNCT04976283
What this trial is testing

Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic SteatohepatitisNAFLD
Getz Pharma 123
Not applicableUnknownNCT04540731
What this trial is testing

Multicenter Registry of Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hospital Italiano de Buenos Aires 2,000
Not applicableStudy completedNCT06491342
What this trial is testing

Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver, Nonalcoholic
Phramongkutklao College of Medicine and Hospital 90
Large-scale testing (Phase 3)UnknownNCT03970031
What this trial is testing

MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH

Who this might be right for
Type2 DiabetesNASH - Nonalcoholic SteatohepatitisNonalcoholic Steatohepatitis+1 more
Cirius Therapeutics, Inc. 1,800
Not applicableStudy completedNCT02018237
What this trial is testing

High Fructose Corn Syrup

Who this might be right for
Nonalcoholic Fatty Liver DiseaseObesity
Washington University School of Medicine 47
Testing effectiveness (Phase 2)Study completedNCT04031729
What this trial is testing

Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Massachusetts General Hospital 80
Large-scale testing (Phase 3)Study completedNCT01992809
What this trial is testing

Omega 3 Supplementation in Fatty Liver

Who this might be right for
Fatty Liver
University of Sao Paulo General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04773964
What this trial is testing

Study to Evaluate MET642 in Patients With NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Metacrine, Inc. 215
Large-scale testing (Phase 3)Study completedNCT01051219
What this trial is testing

Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

Who this might be right for
Nonalcoholic Steatohepatitis
Newcastle-upon-Tyne Hospitals NHS Trust 45
Not applicableStudy completedNCT05081427
What this trial is testing

Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2

Who this might be right for
Nonalcoholic Fatty Liver
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT04134091
What this trial is testing

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Lipocine Inc. 56
Not applicableStudy completedNCT03897218
What this trial is testing

Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - "A Diet for Liver Health"

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
RWTH Aachen University 84
Post-approval studies (Phase 4)Study completedNCT03434613
What this trial is testing

Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseDyslipidemias
Yonsei University 64
Not applicableUnknownNCT04861012
What this trial is testing

Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt

Who this might be right for
Steatohepatitis, Nonalcoholic
Assiut University 360
Early research (Phase 1)Study completedNCT03748628
What this trial is testing

Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 8
Next Page